SYK
Stryker Corporation
Medical Devices · Healthcare · United States
311.75
close · 2026-10-29
value
36
cheaper than peers36
quality
88
stronger fundamentals88
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 18.72× | 65 |
| EV to EBITDA | 17.43× | 45 |
| price to book | 4.98× | 31 |
| price to sales | 4.63× | 27 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 27.0% | 97 |
| return on equity | 16.5% | 89 |
| revenue growth | 9.4% | 55 |
| debt to equity | 64.4% | 42 |
4 of 4 measures available
Facts
| market cap | $120B |
| free cash flow | $4.11B |
| employees | 56,000 |
| first trade | 1980-03-17 |
| next earnings | 2026-10-29 |
| fundamentals updated | 2026-10-29 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 8.40 | 7.76 | 8.25 | 6.17 |
| free cash flow | $4.28B | $3.49B | $3.14B | $2.04B |
| net income | $3.25B | $2.99B | $3.17B | $2.36B |
| revenue | $25.12B | $22.59B | $20.50B | $18.45B |
| unusual items | -$170.0M | -$977.0M | -$36.0M | -$270.0M |